Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind active-controlled trial of Recombinant Zoster Vaccine (CHO cell)
CTR20263116Phase 3Active
- Sponsor
- Yidao Biotechnology
- Start
- Aug 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Yidao Biotechnology. Started Aug 2026; status: active.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20263116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263116.